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Collision tumors of the sellar region are relatively uncommon and consist mainly of more than one type of pituitary
adenoma or a cyst or cystic tumor. The association of a pituitary adenoma and a craniopharyngioma is particularly
rare. This study describes a rare occurrence in which a pituitary adenoma and a craniopharyngioma coexisted in the
sellar region. The case involves a 47-year-old woman who underwent transsphenoidal surgery with subtotal tumor
resection and reoperation using an interhemispheric transcallosal approach for total microsurgical resection of the
tumor because the visual acuity in her left eye had re-deteriorated. Histopathological and immunohistochemical
examinations of the excised tissue revealed a pituitary adenoma in the first operation and a craniopharyngioma in
the second operation. Retrospective analysis found the coexistence of a pituitary adenoma and a
craniopharyngioma, known as a collision tumor. Instead of the transsphenoidal approach, a craniotomy should be
performed, to explore the suprasellar region.
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Pituitary adenomas and craniopharyngiomas are two types
of common tumors in the sellar or suprasellar areas. Pitu-
itary tumors represent 10% to 15% of all intracranial tu-
mors, with an annual incidence of 0.2 to 2.8 cases per
100,000 persons [1]. Craniopharyngiomas represent 1% to
4% of all primary intracranial neoplasms and occur at a
rate of 1.3 per million person years [2]. The coexistence of
these two neoplasms in the sellar or suprasellar areas is
rare, and both lesions can attain a large size and cause
similar signs and symptoms. This similarity makes the
diagnosis and treatment of these coexisting tumors diffi-
cult. In this report, we present a case in which a pituitary
adenoma and a craniopharyngioma were found to coexist.
The case involves a 47-year-old woman who underwent
transsphenoidal surgery with subtotal pituitary adenoma
resection and reoperation using an interhemispheric* Correspondence: liufushengs@hotmail.com
1Brain Tumor Research Center, Beijing Neurosurgical Institute & Department
of Neurosurgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing
100050, China
Full list of author information is available at the end of the article
© 2013 Jin et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the ortranscallosal approach for total microsurgical resection of
the craniopharyngioma.Case presentation
History and examination
A 47-year-old right-handed woman presented with inter-
mittent blurred vision of the left eye and headaches, which
she had had for 5 months. She had also suffered from sore
roughening or splitting of the palms and arches for
6 months. The patient had been pregnant twice with nor-
mal deliveries, and she had not reached menopause at ad-
mission. Neurological examination revealed no obvious
clinical signs. The patient complained of decreased vision
in her left eye. An examination of her visual acuity re-
vealed that her left eye had almost no distant vision. Visual
field testing showed that her left eye’s mean sensitivity and
mean defect were significantly decreased compared with
the normal value. Ophthalmic fundus examination of both
eyes did not show any obvious abnormality. The vision of
the patient’s right eye was 5/4, and the mean sensitivity
and mean defect were decreased but higher than in the
left eye. An endocrine evaluation revealed increased levels
of prolactin (111.9 ng/ml, reference value: 2 ng/ml toThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 Photomicrographs of the pathological specimen.
(A) Features of pituitary adenoma (H &E, ×100). Negative
immunohistochemical staining for: (B) growth hormone, (C) prolactin,
(D) follicle-stimulating hormone, (E) thyroid-stimulating hormone, (F)
luteinizing hormone, (G) ACTH.
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(116.7 pg/ml, reference value: 11.6 pg/ml to 70.8 pg/ml).
Levels of other hormones, including luteinizing hormone,
growth hormone, and follicle-stimulating hormone were
normal. Other physical examinations revealed that the pa-
tient had no other clinical symptoms, neurologic deficits,
or other hormonal dysfunction. Biochemical evaluations,
including analysis of blood chemistry, electrolyte levels,
and urine did not show any obvious abnormality. Com-
puted tomography (CT) and magnetic resonance imaging
(MRI) of the patient’s brain revealed an abnormal signal in
the sellar and suprasellar areas, owing to the presence of a
partial contrasting mass with clear edges (Figure 1). The
patient was diagnosed with pituitary adenoma.
Operation and post-operative course
Transsphenoidal surgery was performed. The tumor was
pinkish-gray and soft, and some parts had a rich blood
supply with hemorrhage. Subtotal tumor resection was
achieved. Staining with H & E revealed a pituitary aden-
oma consisting of a diffused expansion of cells with
pseudo-acinar and pseudo-papillary features (Figure 2A).
Immunohistochemical stains for growth hormone, pro-
lactin, follicle-stimulating hormone, thyroid-stimulating
hormone, luteinizing hormone, and ACTH were negative,
revealing a nonfunctional pituitary adenoma (Figure 2B-G).
After surgery, the patient had transient diabetes insipidus
and hyponatremia, but she demonstrated fast recovery
and her vision improved.Figure 1 Preoperative images of computed tomography (CT)
and magnetic resonance imaging (MRI) scans. (A) Sagittal CT
showing isodensity or slightly higher density in the sellar and
suprasellar areas (arrow indicates the cystic mass in the suprasellar
areas). (B,C) Transverse MRI showing a short T1-weighted signal in
the sellar area and prepontine cistern and a short T2-weighted
signal (arrows indicate the mass). (D-F) Contrast MRI showing an
enhanced mass in the sellar and suprasellar areas with a cystic mass
in the prepontine cistern (D,F; arrows indicate the mass. E; arrow
indicates the cystic mass in the prepontine cistern).Second admission and examination
After 4 months, a follow-up MRI showed an enlarged re-
gion of isodensity in the suprasellar and prepontine areas
(Figure 3, arrow point). An enlarged mass corresponding
to the ‘cystic lesion’ area was observed in the preoperative
image (Figure 1A and E, arrow point). After retrospective
analysis, the cystic expansion was believed to be a result of
the decompression caused by pituitary tumor resection.
The patient was followed up because she had no other
clinical symptoms or signs. At 9 months after the initial
operation, the patient complained that the visual acuity ofFigure 3 Post-operative MRI scan showing subtotal tumor
resection (arrow indicated the enlarged cystic mass).
Figure 5 Photomicrographs of the pathological specimen
showing the features of craniopharyngioma: (A) wet keratin
(arrow, H & E, ×100), (B) multiple layers of squamous
epithelium (H & E, ×200).
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came back to our hospital for further examination. Oph-
thalmologic examination revealed that the status of her
left eye was very poor, with almost no visual acuity, and
she was not able to maintain visual field detection. Her
right eye visual acuity had decreased slightly compared
with the previous evaluation (from 5/4 to 5/5), and its vis-
ual field was also decreased. Ophthalmic fundus examin-
ation of both eyes did not show any obvious abnormality.
Endocrinological testing showed normal levels of prolac-
tin, ACTH, follicle-stimulating hormone, luteinizing hor-
mone, growth hormone, and free T4 with only slightly
decreased levels of free T3 (1.72 nmol/l, reference value:
2.2 nmol/l to 4.2 nmol/l) and thyroid-stimulating hormone
(0.3 μIU/ml, reference value: 0.47 μIU/ml to 4.95 μIU/ml).
Sagittal CT and MRI showed an abnormal mixed signal in
the suprasellar area and the prepontine cistern, corre-
sponding to a partial contrasting mass with clear edges
(Figure 4, arrow point). The patient was diagnosed with
recurrent pituitary adenoma.Second operation and post-operative course
The patient underwent a right frontal craniotomy using
an interhemispheric transcallosal approach for total mic-
rosurgical resection of the tumor. The tumor was situated
in the suprasellar area and premesencephalon. It was
cystic, soft, and yellow-white. Histopathological studies
revealed an adamantinomatous craniopharyngioma char-
acterized by squamous epithelium arranged in a trabecular
pattern as well as nodules of wet keratin (Figure 5). The
post-operative course of the patient was uneventful, with
the exception of transient diabetes insipidus and hypo-
natremia. Endocrinologic testing showed only that levels
of free T3 and thyroid-stimulating hormone were slightly
lower than normal. The patient’s visual acuity improved
again. After 3 months, a follow-up MRI confirmed com-
plete resection of the tumor (Figure 6).Figure 4 CT and MRI scans 11 months after the first operation.
(A) Sagittal CT showing the isodensity in the suprasellar area and
the prepontine cistern (arrow). (B) MRI showing a partial contrasting
mass in the suprasellar area (arrow).Discussion
Collision tumors represent two morphologically different
tumors that are attached to each other [3]. Although pituit-
ary adenomas and craniopharyngiomas are two of the most
common tumors in the sellar or suprasellar areas, the co-
existence of a pituitary adenoma and a craniopharyngioma
is rare. Only a few cases have been reported; their clinico-
pathological features are summarized in Table 1 [4-16].
Table 1 summarizes 14 cases (including two cases reported
in China in Chinese) of tumors found in ten men and four
women with ages ranging from 12 to 75. The prolactin
type of pituitary adenoma was the most frequent (eight
cases), in addition, there were two cases of ACTH (includ-
ing the present case) and one case of thyroid-stimulating
hormone; the remaining cases were the nonfunctional or
silent type. The most well-documented cases of cranio-
pharyngioma have been of the adamantinomatous type.Figure 6 Sagittal T1-weighted MRI scan obtained 3 months
after second surgery, revealing total tumor resection.
Table 1 Literature review for the coexistence of pituitary adenoma with craniopharyngioma
Case Report
year
Age, sex Symptom, duration Hyperprolactinemia 1st treatment, pathology Post-operative course Pathologic type of
pituitary adenoma
Follow up
1. [4] 1971 29, male Acromegaly Right frontal craniotomy,
Pituitary adenoma and
craniopharyngioma
Diabetes insipidus Somatotroph Died 4 days after operation;
uncontrolled diabetes
insipidus





2nd surgery : Craniotomy
due to regrowth of
craniopharyngioma
(December 1979)












Prolactin Autopsy confirmed pituitary
adenoma
Died from cardiac arrest.










2nd surgery: right frontal
craniotomy for
craniopharyngioma
5. [8] 1987 47, male Deteriorating vision + Transsphenoidal, Pituitary
adenoma
1st surgery: visual acuity




















2nd surgery: craniotomy for
craniopharyngioma









































Table 1 Literature review for the coexistence of pituitary adenoma with craniopharyngioma (Continued)








No recurrence in 4 years
10. [13] 2009 59, male Progressive vision loss Subtotal transcranial
resection
Transient diabetes insipidus Gonadotrophic
hormone
Not known






MRI performed 8 months
post-operatively; 10 months
after operation no tumor
recurrence







No recurrence in 1 year
13. [16] 2013 75, female Diplopia + Transsphenoidal, Composite
pituitary adenoma and
craniopharyngioma








1st surgery: visual acuity
deteriorated 9 months
post-operatively
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vision and symptoms caused by the abnormal secretion of
hormones. These features are similar to those of pituitary
adenoma or craniopharyngioma alone. No obvious fea-
tures were observed in CT and MRI images to identify this
coexistence.
Given the similarities of the clinical and imaging fea-
tures to those of pituitary adenomas, a preoperative
diagnosis of a dual pathological condition of the sella is
highly difficult. A definitive diagnosis of a collision sellar
lesion is usually based on histological studies. In this
case, preoperative MRI showed two abnormal masses at-
tached to each other with different signal intensities
(Figure 1A,E). The calcification on the CT imaging in
Figure 1A was ignored at first, and the preoperative
imaging findings were considered to indicate a pituitary
adenoma with cystic changes. The cystic mass was
expected to shrink naturally after transsphenoidal sur-
gery of the pituitary adenoma, but instead it increased in
size after the surgery. The cystic mass was still not given
sufficient attention, and it was believed that the cystic
dilatation had been caused by the decreased pressure
after removal of the pituitary adenoma. It was only when
the patient’s visual acuity in her left eye deteriorated and
the imaging was repeated that the tumor recurrence was
identified. A review of the histological diagnoses of this
case, namely, a pituitary adenoma in the first operation
and a craniopharyngioma in the second operation, re-
vealed that ‘a pituitary adenoma with cystic changes’ was
in fact coexisting pituitary adenoma and craniopharyn-
gioma and that ‘the cystic changes’ were features of a
craniopharyngioma lesion. Although the transsphenoidal
approach is the first choice for the resection of most pi-
tuitary adenomas, craniotomy should be performed to
explore the suprasellar region for coexisting tumors. If
the cystic part can be identified as a craniopharyngioma
during the first procedure, a craniotomy should be per-
formed to explore the suprasellar region, rather than the
transsphenoidal approach, and a second surgery might
thereby be avoided. After the second operation, the tumor
was completely removed surgically using the interhemis-
pheric transcallosal approach. During a follow-up period
of 3 months, the patient was alive and well, with no evi-
dence of disease progression. MRI showed total tumor re-
section with post-surgical changes (Figure 6).
The tumorigenesis of the coexisting pituitary adenoma
and craniopharyngioma is unclear. Yoshida et al. [11]
reported a case of pituitary adenoma intermingled with
adamantinomatous craniopharyngioma-like components
in a young man, but an intermediate morphological
phenotype was not found between the two types of tumor.
Gokden and Mrak [15] reported a nonfunctioning pituit-
ary adenoma with an intermingled craniopharyngioma
component that did not form two distinct lesions. In theirstudy, a histological delineation was also absent, although
multiple foci corresponding to the transition from an or-
dinary pituitary adenoma to an adenoma with squamoid
and then adamantinomatous areas were described by
pathological examination. Moshkin et al. [14] reported a
collision tumor, and histological analysis revealed it to be
an adamantinomatous craniopharyngioma. However, elec-
tron microscopy showed adenoma cells with the ultra-
structural features of a silent pituitary adenoma subtype 3.
Aside from these three cases, in which the pituitary aden-
oma and craniopharyngioma components were admixed,
additional cases in which the two components are distinct
have been reported. Our study describes another case with
the association of a pituitary adenoma and a craniopha-
ryngioma, in which the two components are separated. In
general, a neoplasm with dual internal phenotypes is can
be explained using metaplastic mechanisms, but the histo-
genesis of the aforementioned collision tumors is still un-
certain. Among the cases of collision tumors listed in
Table 1, eight cases had hyperprolactinemia. With respect
to the tumorigenesis of these types of concurrent tumor,
Cusimano et al. [10] postulated that the loss of the inhibi-
tory hypothalamic dopaminergic input due to pituitary
stalk compression by craniopharyngioma is intimately as-
sociated with the pathogenesis of lactotroph hyperplasia
and prolactinoma. In updated cases, reports on the patho-
logical types of pituitary adenomas other than prolactinoma
are available. However, the malfunction of hypothalamic
dopaminergic input caused by craniopharyngioma does not
explain the formation of nonfunctional or ACTH adenoma.
A determination of the mechanisms responsible for the
collision coexistence of the two tumor types requires fur-
ther study.Conclusions
The concurrence of pituitary adenoma and cranio-
pharyngioma is rare and represents a serious problem in
clinical and imaging diagnoses. If we had been aware of
the possibility of the concurrence (it is completely pos-
sible to make a correct diagnosis based on pathology
and imaging characteristics), we would have avoided the
second operation resulting from the misdiagnosis. For a
patient with a pituitary adenoma and craniopharyngioma
collision tumor, a craniotomy should be performed to ex-
plore the suprasellar region, rather than a transsphenoidal
approach.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the editor-in-chief of this journal.
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